In the context of cancer, TGF-β signalling can trigger epithelial–mesenchymal transition (EMT), a process wherein epithelial cells transition to a mesenchymal phenotype, thereby gaining increased migratory and invasive capacities [8,9]. Here, TGFB1 is linked to cancer.